共 50 条
Upregulation of Steroidogenic Acute Regulatory Protein by Hypoxia Stimulates Aldosterone Synthesis in Pulmonary Artery Endothelial Cells to Promote Pulmonary Vascular Fibrosis
被引:58
|作者:
Maron, Bradley A.
[1
,4
]
Oldham, William M.
[2
]
Chan, Stephen Y.
[1
]
Vargas, Sara O.
[3
,5
]
Arons, Elena
[1
]
Zhang, Ying-Yi
[1
]
Loscalzo, Joseph
[1
]
Leopold, Jane A.
[1
]
机构:
[1] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Vet Affairs Boston Healthcare Syst, Dept Cardiol, Boston, MA USA
[5] Boston Childrens Hosp, Dept Pathol, Boston, MA USA
基金:
美国国家卫生研究院;
关键词:
aldosterone;
cell hypoxia;
fibrosis;
hypertension;
pulmonary;
C-FOS;
ADRENOCORTICAL-CELLS;
GLOMERULOSA CELLS;
ANGIOTENSIN-II;
HEART-FAILURE;
HYPERTENSION;
GENE;
RATS;
EXPRESSION;
SYNTHASE;
D O I:
10.1161/CIRCULATIONAHA.113.007690
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background-The molecular mechanism(s) regulating hypoxia-induced vascular fibrosis are unresolved. Hyperaldosteronism correlates positively with vascular remodeling in pulmonary arterial hypertension, suggesting that aldosterone may contribute to the pulmonary vasculopathy of hypoxia. The hypoxia-sensitive transcription factors c-Fos/c-Jun regulate steroidogenic acute regulatory protein (StAR), which facilitates the rate-limiting step of aldosterone steroidogenesis. We hypothesized that c-Fos/c-Jun upregulation by hypoxia activates StAR-dependent aldosterone synthesis in human pulmonary artery endothelial cells (HPAECs) to promote vascular fibrosis in pulmonary arterial hypertension. Methods and Results-Patients with pulmonary arterial hypertension, rats with Sugen/hypoxia-pulmonary arterial hypertension, and mice exposed to chronic hypoxia expressed increased StAR in remodeled pulmonary arterioles, providing a basis for investigating hypoxia-StAR signaling in HPAECs. Hypoxia (2.0% FiO(2)) increased aldosterone levels selectively in HPAECs, which was confirmed by liquid chromatography-mass spectrometry. Increased aldosterone by hypoxia resulted from enhanced c-Fos/c-Jun binding to the proximal activator protein-1 site of the StAR promoter in HPAECs, which increased StAR expression and activity. In HPAECs transfected with StAR-small interfering RNA or treated with the activator protein-1 inhibitor SR-11302 [3-methyl-7-(4-methylphenyl)-9-(2,6,6-trimethylcyclohexen1-yl) nona-2,4,6,8-tetraenoic acid], hypoxia failed to increase aldosterone, confirming that aldosterone biosynthesis required StAR activation by c-Fos/c-Jun. The functional consequences of aldosterone were confirmed by pharmacological inhibition of the mineralocorticoid receptor with spironolactone or eplerenone, which attenuated hypoxia-induced upregulation of the fibrogenic protein connective tissue growth factor and collagen III in vitro and decreased pulmonary vascular fibrosis to improve pulmonary hypertension in vivo. Conclusion-Our findings identify autonomous aldosterone synthesis in HPAECs attributable to hypoxia-mediated upregulation of StAR as a novel molecular mechanism that promotes pulmonary vascular remodeling and fibrosis.
引用
收藏
页码:168 / U146
页数:35
相关论文